Researchers Question Safety, Value Of Untested Stem Cell Treatments

NPR, 5 September 2016
Author: Rob Stein
“So far the Food and Drug Administration has not aggressively regulated stem cell clinics. The reason is the stem cells being used typically come from the patient’s own body — an autologous transplant. And the clinics don’t process the cells much before injecting them. But now that the treatments are being offered so much more widely, the FDA is considering more aggressive regulation. As part of that process, the agency will hold a workshop this Thursday, followed by a two-day hearing next week.”
Find article here.